Dhaval Patel

NPI: 1902966591
Total Payments
$5,783
2024 Payments
$20.07
Companies
34
Transactions
352
Medicare Patients
2,522
Medicare Billing
$259,287

Payment Breakdown by Category

Food & Beverage$5,372 (92.9%)
Education$180.44 (3.1%)
Consulting$125.00 (2.2%)
Other$105.00 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,372 342 92.9%
Education $180.44 8 3.1%
Consulting Fee $125.00 1 2.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $105.00 1 1.8%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $890.55 72 $0 (2024)
AstraZeneca Pharmaceuticals LP $622.95 39 $0 (2018)
Lilly USA, LLC $536.48 36 $0 (2022)
Amgen Inc. $535.60 29 $0 (2018)
Shire North American Group Inc $361.24 10 $0 (2018)
Janssen Pharmaceuticals, Inc $356.24 33 $0 (2018)
SANOFI-AVENTIS U.S. LLC $332.64 22 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $279.57 14 $0 (2018)
Abbott Laboratories $217.26 11 $0 (2021)
Tandem Diabetes Care, Inc. $154.68 4 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $20.07 2 Novo Nordisk Inc ($14.96)
2023 $147.51 1 Actelion Pharmaceuticals US, Inc. ($147.51)
2022 $306.58 10 Novo Nordisk Inc ($169.87)
2021 $13.21 1 Abbott Laboratories ($13.21)
2020 $150.00 4 Esperion Therapeutics, Inc. ($150.00)
2019 $210.27 2 Tandem Diabetes Care, Inc. ($105.27)
2018 $1,962 113 Amgen Inc. ($343.84)
2017 $2,973 219 Novo Nordisk Inc ($378.09)

All Payment Transactions

352 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
10/22/2024 CeQur Corporation CeQur Simplicity (Device) Food and Beverage Cash or cash equivalent $5.11 General
Category: Diabetes
05/14/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.96 General
Category: Diabetes
06/15/2023 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $147.51 General
Category: Cardiology
10/24/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $9.57 General
Category: Diabetes
10/18/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $9.82 General
Category: Diabetes
10/06/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $10.43 General
Category: Diabetes
09/02/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $10.24 General
Category: Diabetes
08/23/2022 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage Cash or cash equivalent $125.00 General
Category: Diabetes
06/09/2022 Lilly USA, LLC Education In-kind items and services $11.71 General
05/03/2022 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $93.34 General
Category: Diabetes
04/19/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $11.68 General
Category: Diabetes
02/13/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.36 General
Category: Diabetes
02/01/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $10.43 General
Category: Diabetes
12/26/2021 Abbott Laboratories FreeStyle Libre (Device) Food and Beverage In-kind items and services $13.21 General
Category: Diabetes Care
11/03/2020 Esperion Therapeutics, Inc. NEXLETOL (Drug) Education In-kind items and services $40.00 General
Category: ANTILIPEMIC AGENTS
11/03/2020 Esperion Therapeutics, Inc. NEXLETOL (Drug) Education In-kind items and services $35.00 General
Category: ANTILIPEMIC AGENTS
11/02/2020 Esperion Therapeutics, Inc. NEXLETOL (Drug) Education In-kind items and services $40.00 General
Category: ANTILIPEMIC AGENTS
11/02/2020 Esperion Therapeutics, Inc. NEXLETOL (Drug) Education In-kind items and services $35.00 General
Category: ANTILIPEMIC AGENTS
06/05/2019 Tandem Diabetes Care, Inc. t-slim insulin pump (Device) Food and Beverage Cash or cash equivalent $105.27 General
Category: Endocrinology
05/08/2019 GENZYME CORPORATION SOLIQUA 100/33 (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $105.00 General
Category: DIABETES
11/23/2018 Abbott Laboratories FreeStyle Libre Pro (Device) Food and Beverage In-kind items and services $5.96 General
Category: Diabetes Care
07/19/2018 Abbott Laboratories FreeStyle Libre blood glucose Flash Monitoring System (Device) Food and Beverage In-kind items and services $15.65 General
Category: Diabetes Care
07/19/2018 Abbott Laboratories FreeStyle Libre blood glucose Flash Monitoring System (Device) Food and Beverage In-kind items and services $6.39 General
Category: Diabetes Care
07/11/2018 Abbott Laboratories FreeStyle Libre blood glucose Flash Monitoring System (Device) Food and Beverage In-kind items and services $6.54 General
Category: Diabetes Care
06/20/2018 SANOFI-AVENTIS U.S. LLC TOUJEO (Drug) Food and Beverage In-kind items and services $19.17 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 572 2,320 $235,225 $66,201
2022 8 589 2,390 $230,082 $65,022
2021 8 595 2,337 $233,582 $65,732
2020 12 766 2,616 $260,067 $62,332
Total Patients
2,522
Total Services
9,663
Medicare Billing
$259,287
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 180 326 $94,866 $27,407 28.9%
J0897 Injection, denosumab, 1 mg Office 2023 15 1,320 $80,520 $24,396 30.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 41 41 $18,081 $4,441 24.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 44 51 $10,251 $2,844 27.7%
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes Office 2023 19 56 $10,920 $2,240 20.5%
83036 Hemoglobin a1c level Office 2023 113 229 $8,015 $2,152 26.8%
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report Office 2023 35 67 $8,442 $1,682 19.9%
82947 Blood glucose (sugar) level Office 2023 109 204 $2,856 $774.23 27.1%
96372 Injection of drug or substance under skin or into muscle Office 2023 16 26 $1,274 $265.50 20.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 191 330 $96,030 $28,814 30.0%
J0897 Injection, denosumab, 1 mg Office 2022 19 1,440 $86,490 $24,106 27.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 39 39 $17,199 $4,264 24.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 49 61 $12,261 $3,498 28.5%
83036 Hemoglobin a1c level Office 2022 127 230 $8,050 $2,121 26.4%
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report Office 2022 23 46 $5,796 $1,124 19.4%
82947 Blood glucose (sugar) level Office 2022 122 220 $3,080 $831.63 27.0%
96372 Injection of drug or substance under skin or into muscle Office 2022 19 24 $1,176 $263.87 22.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 201 355 $103,305 $30,738 29.8%
J0897 Injection, denosumab, 1 mg Office 2021 14 1,320 $80,520 $21,717 27.0%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 38 38 $16,758 $4,497 26.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 62 73 $14,673 $4,313 29.4%
83036 Hemoglobin a1c level Office 2021 122 242 $8,470 $2,251 26.6%
95251 Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours Office 2021 22 40 $5,040 $1,025 20.3%
82947 Blood glucose (sugar) level Office 2021 121 239 $3,346 $895.55 26.8%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 15 30 $1,470 $295.38 20.1%

About Dhaval Patel

Dhaval Patel is a Internal Medicine healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902966591.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dhaval Patel has received a total of $5,783 in payments from pharmaceutical and medical device companies, with $20.07 received in 2024. These payments were reported across 352 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,372).

As a Medicare-enrolled provider, Patel has provided services to 2,522 Medicare beneficiaries, totaling 9,663 services with total Medicare billing of $259,287. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Diabetes & Metabolism
  • Location High Point, NC
  • Active Since 12/12/2006
  • Last Updated 01/31/2011
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1902966591

Products in Payments

  • FARXIGA (Drug) $622.95
  • Ozempic (Drug) $407.99
  • NATPARA (Drug) $361.24
  • Prolia (Biological) $331.46
  • INVOKANA (Drug) $330.56
  • JARDIANCE (Drug) $307.42
  • Victoza (Drug) $271.77
  • Repatha (Biological) $204.14
  • TOUJEO (Drug) $190.50
  • FreeStyle Libre blood glucose Flash Monitoring System (Device) $165.19
  • t-slim insulin pump (Device) $154.68
  • BASAGLAR (Drug) $152.76
  • NEXLETOL (Drug) $150.00
  • UPTRAVI (Drug) $147.51
  • SOLIQUA (Drug) $142.14
  • JANUVIA (Drug) $137.57
  • Korlym (Drug) $129.89
  • Dexcom G5 Mobile CGM System (Device) $126.01
  • MOUNJARO (Drug) $125.00
  • SOLIQUA 100/33 (Drug) $105.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in High Point